4.3 Review

The diagnosis of pleural effusions

Journal

EXPERT REVIEW OF RESPIRATORY MEDICINE
Volume 9, Issue 6, Pages 801-815

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/17476348.2015.1098535

Keywords

chylothorax; empyema; heart failure; hepatic hydrothorax; malignant pleural effusion; mesothelioma; pleural effusion; tuberculosis

Funding

  1. Western Australia Cancer & Palliative Care Network clinical fellowship
  2. NHMRC
  3. New South Wales Dust Disease Board
  4. Sir Charles Gairdner Research Advisory Committee
  5. Rocket UK Ltd
  6. Roche UK

Ask authors/readers for more resources

Pleural effusions arise from a variety of systemic, inflammatory, infectious and malignant conditions. Their precise etiological diagnosis depends on a combination of medical history, physical examination, imaging tests and pertinent pleural fluid analyses; including specific biomarkers (e.g., natriuretic peptides for heart failure, adenosine deaminase for tuberculosis, or mesothelin for mesothelioma). Invasive procedures, such as pleuroscopic biopsies, may be required for persistently symptomatic effusions which remain undiagnosed after the analysis of one or more pleural fluid samples. However, whenever parietal pleural nodularity or thickening exist, image-guided biopsies should first be attempted. This review addresses the current diagnostic approach to pleural effusions secondary to heart failure, pneumonia, cancer, tuberculosis and other less frequent conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available